These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3131465

  • 21. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [Abstract] [Full Text] [Related]

  • 22. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S, Hazra SK, Saha B, Mazumder B, Biswas PC, Chattopadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [Abstract] [Full Text] [Related]

  • 23. Adoptive transfer of tolerance induced by ICRC bacilli against Mycobacterium leprae in mice.
    Jeevan A, Bapat CV, Deo MG.
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):437-45. PubMed ID: 3528346
    [Abstract] [Full Text] [Related]

  • 24. Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies.
    Britton WJ, Hellqvist L, Garsia RJ, Basten A.
    Clin Exp Immunol; 1987 Jan; 67(1):31-42. PubMed ID: 3304738
    [Abstract] [Full Text] [Related]

  • 25. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
    Gill HK, Mustafa AS, Godal T.
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
    [Abstract] [Full Text] [Related]

  • 26. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [Abstract] [Full Text] [Related]

  • 27. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A, Gaur SP, Kaushal GP, Misra A, Asthana P, Sircar AR.
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [Abstract] [Full Text] [Related]

  • 28. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG.
    Indian J Lepr; 1984 Jun; 56(4):764-75. PubMed ID: 6442720
    [Abstract] [Full Text] [Related]

  • 29. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK, Sharma AK, Misra RS, Zaheer SA, Mukherjee A, Mukherjee R, Beena KR, Kaur H, Nair SK, Talwar GP.
    Indian J Lepr; 1992 Jun; 64(4):495-500. PubMed ID: 1308525
    [Abstract] [Full Text] [Related]

  • 30. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ, Draper P, Payne SN, Rees RJ.
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [Abstract] [Full Text] [Related]

  • 31. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL, Ramanathan VD, Gupte MD.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [Abstract] [Full Text] [Related]

  • 32. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine.
    Mistry NF, Antia NH.
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):110-3. PubMed ID: 2659695
    [No Abstract] [Full Text] [Related]

  • 33. Post-vaccination sensitization with ICRC vaccine.
    Vallishayee RS, Gupte MD, Anantharaman DS, Nagaraju B.
    Indian J Lepr; 1996 Mar; 68(2):167-74. PubMed ID: 8835586
    [Abstract] [Full Text] [Related]

  • 34. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD, Vallishayee RS, De Britto LJ, Anantharaman DS.
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH, Hunter SW, Murray LP, Siu P, Tsang M, Brennan PJ.
    Lepr Rev; 1994 Sep 15; 65(3):175-80. PubMed ID: 8942148
    [Abstract] [Full Text] [Related]

  • 40. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Martin LN, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Int J Lepr Other Mycobact Dis; 2000 Mar 15; 68(1):27-39. PubMed ID: 10834067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.